|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.946 EUR | -0.88% |
|
-3.77% | -9.25% |
| 06-30 | Evotec Expands Prefabricated Drug Manufacturing Offerings | MT |
| 06-30 | Just ? Evotec Biologics Launches J.TRAIN Turnkey Continuous Manufacturing Platform For Biologics | CI |
Company Valuation: Evotec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,444 | 2,696 | 3,765 | 1,453 | 966.4 | 879.1 | - | - |
| Change | - | -63.78% | 39.63% | -61.41% | -33.49% | -9.03% | - | - |
| Enterprise Value (EV) 1 | 7,099 | 2,485 | 3,787 | 1,669 | 938.7 | 893.4 | 948.5 | 929.8 |
| Change | - | -65% | 52.43% | -55.93% | -43.75% | -4.83% | 6.16% | -1.97% |
| P/E | 32.7x | -15.4x | -45.3x | -7.38x | -9.4x | -6.96x | -25.3x | 26.5x |
| PBR | 5.44x | 2.27x | 3.37x | 6.89x | 1.19x | 1.29x | 1.36x | 1.3x |
| PEG | - | 0x | 0.9x | -0x | 0.2x | -0.3x | 0.3x | -0x |
| Capitalization / Revenue | 12x | 3.59x | 4.82x | 1.82x | 1.23x | 1.19x | 1.07x | 0.98x |
| EV / Revenue | 11.5x | 3.31x | 4.85x | 2.09x | 1.19x | 1.21x | 1.16x | 1.04x |
| EV / EBITDA | 66.2x | 24.4x | 57.1x | 74x | 22.8x | 27.4x | 11.2x | 6.64x |
| EV / EBIT | 173x | 119x | -142x | -11.7x | -16.7x | -9.99x | -105x | 16.9x |
| EV / FCF | 2,155x | 114x | -21.4x | -16.8x | -11.5x | -6.25x | -23.2x | 30x |
| FCF Yield | 0.05% | 0.88% | -4.67% | -5.95% | -8.71% | -16% | -4.3% | 3.33% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.3 | -0.99 | -0.47 | -1.11 | -0.58 | -0.7105 | -0.1952 | 0.1864 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 618 | 751.4 | 781.4 | 797 | 788.4 | 737.6 | 817.8 | 896.5 |
| EBITDA 1 | 107.3 | 101.7 | 66.35 | 22.56 | 41.1 | 32.62 | 84.42 | 140.1 |
| EBIT 1 | 41 | 20.85 | -26.63 | -142.5 | -56.2 | -89.48 | -9.023 | 55.04 |
| Net income 1 | 215.5 | -175.7 | -83.91 | -196.1 | -103.5 | -113.2 | -30.42 | 44.97 |
| Net Debt 1 | -345.3 | -211.8 | 22.09 | 216 | -27.66 | 14.3 | 69.32 | 50.65 |
| Reference price 2 | 42.500 | 15.260 | 21.280 | 8.195 | 5.450 | 4.946 | 4.946 | 4.946 |
| Nbr of stocks (in thousands) | 175,162 | 176,703 | 176,936 | 177,303 | 177,323 | 177,749 | - | - |
| Announcement Date | 4/12/22 | 5/12/23 | 4/24/24 | 4/17/25 | 4/8/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.96x | 1.21x | 27.39x | -.--% | 1.01B | |
| 35.38x | 6.18x | 19.12x | 0.93% | 50.73B | |
| -23.4x | 342.07x | -22.1x | -.--% | 39.73B | |
| 25.29x | 2.8x | 12.09x | -.--% | 34.69B | |
| 45.73x | 4.51x | 28.9x | -.--% | 33.21B | |
| 27.05x | 7.93x | 19.91x | 0.42% | 26.76B | |
| 31.75x | 5.12x | 23.32x | -.--% | 15.37B | |
| 23.95x | 2.04x | 8.96x | 1.12% | 13.78B | |
| 23.74x | 1.89x | 11.45x | -.--% | 12.85B | |
| Average | 20.28x | 41.53x | 14.34x | 0.27% | 25.35B | |
| Weighted average by Cap. | 22.36x | 63.54x | 11.66x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EVT Stock
- Valuation Evotec SE
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
